These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2802572)

  • 21. [Rimantadine in the prevention and treatment of influenza A].
    Hannoun C
    Rev Med Interne; 1988; 9(5):554-8. PubMed ID: 3067304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amantadine may be lifesaving in severe influenza A.
    Cunha BA
    Clin Infect Dis; 2006 Nov; 43(10):1372-3. PubMed ID: 17051511
    [No Abstract]   [Full Text] [Related]  

  • 23. [The rimantadine sensitivity spectrum in influenza A viruses circulating in the 2002-2004 epidemic seasons].
    Shevchenko ES; Burtseva EI; Slepushkin AN; Merkulova LN; Gatich RZ; Ivanova VT; Oskerko TA
    Vopr Virusol; 2005; 50(5):32-5. PubMed ID: 16250597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Study of rimantadine in the USSR: a review of the literature.
    Zlydnikov DM; Kubar OI; Kovaleva TP; Kamforin LE
    Rev Infect Dis; 1981; 3(3):408-21. PubMed ID: 7025146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Remantadine prophylaxis of influenza in an industrial enterprise].
    Smirnov VV; Grigor'ev AV
    Vopr Virusol; 1982; 27(3):375-7. PubMed ID: 7123918
    [No Abstract]   [Full Text] [Related]  

  • 26. Vaccination as a strategy to reduce the emergence of amantadine- and rimantadine-resistant strains of A/Chick/Pennsylvania/83 (H5N2) influenza virus.
    Webster RG; Kawaoka Y; Bean WJ
    J Antimicrob Chemother; 1986 Oct; 18 Suppl B():157-64. PubMed ID: 3793657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection.
    Dolin R; Reichman RC; Madore HP; Maynard R; Linton PN; Webber-Jones J
    N Engl J Med; 1982 Sep; 307(10):580-4. PubMed ID: 7050702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recovery of drug-resistant influenza A virus during therapeutic use of rimantadine.
    Hayden FG; Sperber SJ; Belshe RB; Clover RD; Hay AJ; Pyke S
    Antimicrob Agents Chemother; 1991 Sep; 35(9):1741-7. PubMed ID: 1952841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [New organized approach to rendering medical services to patients during influenza outbreak].
    Romanov IuA; Gorenskaia RA; Kubar' OI; Reĭkh LIa; Padalko IuV
    Ter Arkh; 1984; 56(1):127-8. PubMed ID: 6231740
    [No Abstract]   [Full Text] [Related]  

  • 30. [Study results of the comprehensive influenza prevention with vaccines and remantadine during the influenza A(H1N1) outbreak in 1979].
    Obrosova-Serova NP; Kupriashina LM; Rykhletskaia NS; Volkov VE; Shtunderenko GV
    Vopr Virusol; 1980; (4):425-9. PubMed ID: 7423970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Experience with clinical trials of the new anti-influenza drug rimantadine].
    Zlydnikov DM
    Vrach Delo; 1981 Apr; (4):15-8. PubMed ID: 7269469
    [No Abstract]   [Full Text] [Related]  

  • 32. [Efficacy of remantadin in influenza B].
    Smagulov KZ; Bigimbetova ShSh; Smagulova EG
    Ter Arkh; 1983; 55(9):140-2. PubMed ID: 6227101
    [No Abstract]   [Full Text] [Related]  

  • 33. Influenza antiviral prescribing practices during the 2007-08 and 2008-09 influenza seasons in the setting of increased resistance to oseltamivir among circulating influenza viruses.
    Dharan NJ; Beekmann SE; Fiore A; Finelli L; Uyeki TM; Polgreen PM; Fry AM
    Antiviral Res; 2010 Nov; 88(2):182-6. PubMed ID: 20739002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Virion transcriptase activity of rimantadine-sensitive and rimantadine-resistant variants of human influenza virus.
    Indulen MK; Kalninya VA; Gorodkova NV; Akopova II; Ghendon YuZ
    Acta Virol; 1987 Nov; 31(6):458-62. PubMed ID: 2894138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemotherapy and vaccination: a possible strategy for the control of highly virulent influenza virus.
    Webster RG; Kawaoka Y; Bean WJ; Beard CW; Brugh M
    J Virol; 1985 Jul; 55(1):173-6. PubMed ID: 4009792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States.
    Bright RA; Shay DK; Shu B; Cox NJ; Klimov AI
    JAMA; 2006 Feb; 295(8):891-4. PubMed ID: 16456087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Uncoating of a rimantadine-resistant variant of influenza virus in the presence of rimantadine.
    Bukrinskaya AG; Vorkunova NK; Pushkarskaya NL
    J Gen Virol; 1982 May; 60(Pt 1):61-6. PubMed ID: 7097251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of rimantadine hydrochloride in the treatment of influenza infection of mice.
    Herrmann JE; Bruns M; West K; Ennis FA
    Antiviral Res; 1989 Apr; 11(3):127-35. PubMed ID: 2735758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prevention of the formation of a mutant influenza A virus resistant to rimantadine (alpha-methyl-1-adamantanemethylamine hydrochloride) by using ribavirin (1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide)].
    Pushkarskaia NL; L'vov ND; Galegov GA
    Vopr Virusol; 1980; (3):303-6. PubMed ID: 7434722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Using antiviral agents to control outbreaks of influenza A infection.
    Monto AS
    Geriatrics; 1994 Dec; 49(12):30-4. PubMed ID: 7982583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.